PMCB today
$0.39-$0.00 (-0.98%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minSymmetric Triangle
5 minSymmetric Triangle
Daily trend turns up above $0.50
Key levels
Resistance$0.56
Resistance$0.50
Support$0.30
Latest news & SEC filings
SEC FilingPharmaCyte Biotech, Inc. filed a report on a major company event (Form 8-K)
All PMCB news →About PharmaCyte Biotech
PharmaCyte Biotech is a biotechnology company developing treatments for cancer. Its lead product candidate, CypCaps, uses a technique that encloses modified human cells inside tiny cotton-derived capsules. These capsules are placed near a tumor and are designed to turn a chemotherapy prodrug into its tumor-killing form. The company is initially targeting locally advanced, inoperable pancreatic cancer and operates in the United States, relying on outside parties for manufacturing.
Based on the company's 10-K filed Jul 29, 2026.
Nasdaq · Healthcare
PharmaCyte Biotech, Inc. (PMCB)
What Is the Price Target for PMCB?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is PMCB a Buy or Sell Right Now?
Thesis
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PMCB.
Start Free Trial →Is PMCB Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B
Fair Value
$0.42
15
Moat Score
NONE
2/9
Piotroski Score
-2.5
Altman Z-Score
What Is Smart Money Doing with PMCB?
Insider Signal
BUYING
6 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
UNCHANGED
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PMCB Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-186.83%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for PMCB
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PMCB, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:42:49 | $0.41 | 1,200 | $$492 | BUY |
| 19:25:50 | $0.39 | 1,906 | $$743 | SELL |
| 19:06:22 | $0.40 | 3,047 | $$1K | SELL |
| 18:29:00 | $0.39 | 1,572 | $$613 | SELL |
| 17:56:50 | $0.39 | 9,000 | $$4K | SELL |
5 dark pool trades shown · $$7K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for PharmaCyte Biotech, Inc. (PMCB) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PMCB — frequently asked questions
What is PMCB stock price today?
PharmaCyte Biotech, Inc. (PMCB) is at $0.39, down 0.98% (-$0.00) at the Nov 12, 2026 close.
Why is PMCB stock moving today?
Latest PMCB news — Oct 16, 2026: PharmaCyte Biotech, Inc. filed a report on a major company event (Form 8-K)
Did PMCB beat earnings?
PMCB last reported on Sep 14, 2026: EPS -$0.54 vs -$0.06 expected — a miss of 800.0%.
Does PMCB pay a dividend?
Yes. PMCB's dividend yield is 12.43%.
What are PMCB support and resistance levels?
Support: $0.30. Resistance: $0.50, $0.56, $0.63.
What are insiders doing with PMCB?
Insider activity: BUYING, 6 buys and 0 sells in the last 90 days.
What is the latest news on PMCB?
Oct 16, 2026: PharmaCyte Biotech, Inc. filed a report on a major company event (Form 8-K)